CS
LMAT icon

Comerica Securities’s LeMaitre Vascular LMAT Stock Holding History

Comerica Securities’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,034
Closed -$47.6K – 987
2022
Q4 		$47.6K Buy
+1,034
New +$48.4K ﹤0.01% 719

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Comerica Securities's LMAT Position: Q1 2023 in Review

Comerica Securities sold out of LeMaitre Vascular (LMAT) in Q1 2023, closing a stake of 1,034 shares — an estimated $47.6K sold.

Comerica Securities first reported a position in LMAT in Q4 2022 and held it in 1 quarter. The position peaked at $47.6K in Q4 2022. 184 funds tracked by Wall St. Rank hold LMAT as of Q1 2023.

  • Comerica Securities reported no remaining LeMaitre Vascular position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 1,034 LeMaitre Vascular shares in Q1 2023, an estimated $47.6K.
  • Comerica Securities first reported a position in LeMaitre Vascular in Q4 2022 and held it in 1 quarter.
  • Comerica Securities's LeMaitre Vascular position peaked at $47.6K in Q4 2022.
  • 184 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.